Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sean Hobson"'
Autor:
Nancy Tamburro, Olivia Larbi, Hasina Momotaz, Gi-Ming Wang, Denise K. Feyes, Susan R. Mazanec, Barbara J. Daly, Katherine Daunov, Ming Li, Sarah Rolfe, Cherry Jiang, Samuel N. Rodgers-Melnick, Richard T. Lee, Monica Webb Hooper, Sean Hobson
Publikováno v:
Supportive Care in Cancer. 29:5777-5785
Supportive and integrative oncology services aim to improve the quality of life of cancer patients. This study characterizes the views of these services among cancer patients, caregivers, and providers at a comprehensive cancer center. A cross-sectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97959f924027b1752da9590c68fc18ee
https://doi.org/10.1007/s00520-021-06081-4
https://doi.org/10.1007/s00520-021-06081-4
Autor:
Lionel Ades, Sean Hobson, Thomas Cluzeau, Mikkael A. Sekeres, Rami S. Komrokji, Thomas Prebet, Alan F. List, Alessandro Sanna, Najla HAl Ali, Pierre Fenaux, Marie Sebert, Virginie Eclache, Valeria Santini, Emmanuel Gyan
Publikováno v:
Leukemia Research. 63:72-77
Karyotype according to the revised IPSS is a strong independent prognostic factor for overall survival (OS) in myelodysplastic syndromes (MDS), however established in untreated patients. The prognostic impact of cytogenetics and cytogenetic response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2d91e42a16101d58cd6d0615d8fa208
https://doi.org/10.1016/j.leukres.2017.10.013
https://doi.org/10.1016/j.leukres.2017.10.013
Autor:
Michael K. Keng, Aziz Nazha, Jaroslaw P. Maciejewski, Matt Kalaycio, Mikkael A. Sekeres, David P. Seastone, Sean Hobson
Publikováno v:
Leukemialymphoma. 56(12)
Several prognostic scoring systems have been developed to risk stratify patients with myelodysplastic syndromes (MDS) [1–7]. The International Prognostic Scoring System (IPSS) has been the most wid...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d62346f69c04288dcccd1899c240903
https://pubmed.ncbi.nlm.nih.gov/26037522
https://pubmed.ncbi.nlm.nih.gov/26037522
Autor:
Robert M. Dean, Eric D. Hsi, Ricki Englehaupt, Mikkael A. Sekeres, Betty K. Hamilton, Bartlomiej P Przychodzen, Matthew Rump, Ramon V. Tiu, Alan E. Lichtin, Joy Juersivich, Ronald Sobecks, Matt Kalaycio, Anjali S. Advani, Jaroslaw P. Maciejewski, Sean Hobson, Tomas Radivoyevitch, Holleh D Husseinzadeh, Reda Z. Mahfouz, Edward A. Copelan, Yogen Saunthararajah, Kathleen Cooper, Frederic J. Reu, Lisa Durkin, Marc Earl
BACKGROUND. Mutational inactivation in cancer of key apoptotic pathway components, such as TP53/p53, undermines cytotoxic therapies that aim to increase apoptosis. Accordingly, TP53 mutations are reproducibly associated with poor treatment outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd511ffe54aa3537ce9bfb96e496dc9d
https://europepmc.org/articles/PMC4362268/
https://europepmc.org/articles/PMC4362268/
Autor:
B. Bolwell, Yogen Saunthararajah, Matt Kalaycio, Sudipto Mukherjee, Jay P. Ciezki, Sean Hobson, Eric A. Klein, Edward A. Copelan, Robert Dreicer, Chandana A. Reddy, May Abdel-Wahab, Mikkael A. Sekeres, Anjali S. Advani, Katarina Paulic, Ramon V. Tiu, Jaroslaw P. Maciejewski
Publikováno v:
Journal of the National Cancer Institute. 106(3)
BACKGROUND Exposure to ionizing radiation has been linked to myelodysplastic syndromes (MDS); it is not clear whether therapeutic radiation doses used for prostate cancer pose an increased MDS risk. METHODS We performed a retrospective cohort study o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a75fcb8384a03f800d4aac122763bc
https://pubmed.ncbi.nlm.nih.gov/24577814
https://pubmed.ncbi.nlm.nih.gov/24577814
Autor:
Michaela Liedtke, Ronald Sobecks, Bhumika J. Patel, Sudipto Mukherjee, Matt Kalaycio, Hetty E. Carraway, Sean Hobson, Cassie Zimmerman, Tamara J. Dunn, Aaron T. Gerds, Caner Saygin, Betty K. Hamilton, Katrina Fischer, Mikkael A. Sekeres, Ryan D. Cassaday, Anjali S. Advani, Nikolaos Papadantonakis, Jaime Fensterl
Publikováno v:
Blood. 128:1603-1603
Background: Acute lymphoblastic leukemia (ALL) represents 20% of adult leukemias. With the optimization of doses and schedules of chemotherapy regimens, and incorporation of targeted agents into adult therapy, over 80% of adults with ALL attain a com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e06688cc84c6c2db28c288cbbf657dc0
https://doi.org/10.1182/blood.v128.22.1603.1603
https://doi.org/10.1182/blood.v128.22.1603.1603
Autor:
Bartlomiej P Przychodzen, Mikkael A. Sekeres, Swapna Thota, Michael J. Clemente, Sean Hobson, Tomas Radivoyevitch, Bhumika J. Patel, Cassandra M. Hirsch, Hetty E. Carraway, Jaroslaw P. Maciejewski
Publikováno v:
Blood. 126:5218-5218
Typically MDS affects older adults, with a median age of diagnosis at 71 years. The incidence increases from 2.5 /105 in the 6th decade of life to 30/105 in the 8th to as high as 60/105 in patients >80 years of age. Younger patients are sporadically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22bce116e8cbf928f663ebe0941494cf
https://doi.org/10.1182/blood.v126.23.5218.5218
https://doi.org/10.1182/blood.v126.23.5218.5218
Autor:
Bhumika J. Patel, Manja Meggendorfer, Bartlomiej P Przychodzen, Torsten Haferlach, Hideki Makishima, Kassy E Kneen, Sean Hobson, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Mridul Mukherji, Tomas Radivoyevitch, Niroshan Nadarajah, Srinivasa R. Sanikommu, Aziz Nazha
Publikováno v:
Blood. 126:1645-1645
TET2 mutations are the most common somatic genetic lesions in myeloid neoplasms. TET2 mutant clones have been found also in healthy individuals, increase with age, and convey an increased risk for myeloid clonal diseases. The TET2 gene is very polymo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57dcfcce485a6afb8fda8a335698010d
https://doi.org/10.1182/blood.v126.23.1645.1645
https://doi.org/10.1182/blood.v126.23.1645.1645
Autor:
Matt Kalaycio, E. Blackstone, Hetty E. Carraway, Yogen Saunthararajah, J. Maciejewski, Sudipto Mukherjee, A. Maggiotto, C. Pierce, M.C. Ornstein, P. Elson, Anjali S. Advani, Ahmad Zarzour, S. Ellis, Aaron T. Gerds, Mikkael A. Sekeres, Sean Hobson
Publikováno v:
Leukemia Research. 39:S154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3463ff8d6cf93cb00ae65714184383e5
https://doi.org/10.1016/s0145-2126(15)30311-8
https://doi.org/10.1016/s0145-2126(15)30311-8
Autor:
Stephen D. Nimer, Ross L. Levine, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Franck Rapaport, Sean Hobson, Emily K. Dolezal, Virginia M. Klimek, Alan H. Shih, Christopher Y. Park, Marcel R.M. van den Brink, Mary K Amato, Stephen S. Chung
Publikováno v:
Blood. 124:4611-4611
Therapy-related Myeloid Neoplasms (tMN) comprise a poor risk subset of myelodysplastic syndromes and acute myelogenous leukemia, are increasing in incidence, and represent a serious complication following treatment for primary malignancies. In our pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d5e4994bb1b741f7d1687c7f0fd86fc
https://doi.org/10.1182/blood.v124.21.4611.4611
https://doi.org/10.1182/blood.v124.21.4611.4611